Percheron Therapeutics Ltd (ASX:PER – Get Free Report) insider Ben Price acquired 2,000,000 shares of the stock in a transaction dated Monday, December 22nd. The shares were bought at an average cost of A$0.01 per share, with a total value of A$18,000.00.
Percheron Therapeutics Stock Performance
Percheron Therapeutics Company Profile
Pernod Ricard SA produces and sells wines and spirits worldwide. It offers its products under various brands. The company was founded in 1805 and is headquartered in Paris, France.
See Also
- Five stocks we like better than Percheron Therapeutics
- BNZI Posts Record Q3 Revenue – See What’s Driving It.
- Wall Street Stockpicker Names #1 Stock of 2026
- Trump’s new AI budget just passed — one stock could soar
- Terrifying reason Trump killed the U.S. penny?
- The IRS Strategy Trump Quietly Backed for Retirement Wealth
Receive News & Ratings for Percheron Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Percheron Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
